National Institute of General Medical Sciences; Notice of Closed Meeting, 28570-28571 [2023-09521]

Download as PDF 28570 Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Research Triangle Park, NC 27713 (Virtual Meeting). Contact Person: Varsha Shukla, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Science, 530 Davis Dr., Keystone Bldg, Room 3094, Durham, NC 27713, 984– 287–3288, Varsha.shukla@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: April 28, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–09450 Filed 5–3–23; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Clinical and Basic Science Study Section. Date: June 22–23, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852 (Hybrid Meeting). Contact Person: Rajiv Kumar, Ph.D., Chief, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6705 Rockledge Drive, Bethesda, MD 20892, (301) 827–4612, rajiv.kumar@nih.gov. 17:12 May 03, 2023 Dated: April 28, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–09439 Filed 5–3–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Proposed Reorganization AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) will host a public hearing to enable discussion of the Institute’s proposal to reorganize the Division of Lung Disease (DLD). The proposed reorganization aims to ensure effective oversight, alignment of expertise, and translation of knowledge within and across research areas in the lung disease field. It establishes a new branch structure that will strategically position leadership over DLD programs, balance workload, and enhance depth/ succession planning for ingrained operational sustainability. There will be no impact on the National Center on Sleep Disorders Research as a result of the restructuring. The online forums will allow members of the public to review the reorganization proposals and submit comments. DATES: The first public hearing will take place June 6, 2023, at approximately 11:30 a.m. E.T. during the open session of the National Heart, Lung, and Blood Institute Advisory Committee meeting. The second public hearing will take place on June 7, 2023, from 12:00 p.m. to 1:00 p.m. E.T. using the NHLBI DLD Director’s Twitter account. Any interested person may also file written comments by sending an email to nhlbi_ dld@nhlbi.mail.gov prior to June 7, 2023. The statement should include the individual’s name, and when applicable, professional affiliation. ADDRESSES: The following email address may be used for comments on the reorganization: nhlbi_dld@ nhlbi.mail.gov. SUMMARY: BILLING CODE 4140–01–P VerDate Sep<11>2014 (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Jkt 259001 PO 00000 Frm 00112 Fmt 4703 Sfmt 4703 The link to the videocast for the first public hearing to occur during the open session of the NHLBI Advisory Council meeting will be posted online at: https://www.nhlbi.nih.gov/about/ advisory-and-peer-review-committees/ advisory-council. The second public hearing will be held via Twitter using @NHLBI_ LUNGDir. FOR FURTHER INFORMATION CONTACT: Tony Jackson, Chief of Staff, Division of Lung Disease, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockledge Center I, 6705 Rockledge Drive, 4th Floor, Bethesda 20817, 301–435–0233, nhlbi_dld@ nhlbi.mail.gov. The NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)) requires public notice of proposed reorganization plans. This announcement and the public forum serve as that notice. SUPPLEMENTARY INFORMATION: Dated: April 27, 2023. James F. Gude, Acting Executive Officer, National Heart, Lung and Blood Institute, National Institutes of Health. [FR Doc. 2023–09452 Filed 5–3–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIGMS Initial Review Group Training and Workforce Development Study Section–D; Review of IMSD and PREP Applications. Date: June 8–9, 2023. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 Wisconsin E:\FR\FM\04MYN1.SGM 04MYN1 Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices Avenue, Bethesda, Maryland 20892 (Hybrid Meeting). Contact Person: Marc Rigas, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institutes of General Medical Sciences, National Institute of Health, 45 Center Drive, Room 3AN18C, Bethesda, Maryland 20892, 301–827–0648, marc.rigas@nih.gov. Name of Committee: NIGMS Initial Review Group Training and Workforce Development Study Section–C; Review of G–RISE, IMSD, and PREP Applications. Date: June 15–16, 2023. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 Wisconsin Avenue, Bethesda, Maryland 20892 (Hybrid Meeting). Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, MSC 6200, Bethesda, Maryland 20892, 301–402– 9448, sonia.ortiz-miranda@nih.gov. Information is also available on the Institute’s/Center’s home page: www.nigms.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program No. 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: May 1, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–09521 Filed 5–3–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ddrumheller on DSK120RN23PROD with NOTICES1 Office of the Director; Notice of Charter Renewal In accordance with title 41 of the U.S. Code of Federal Regulations, section 102–3.65(a), notice is hereby given that the Charter for the Center for Scientific Review Advisory Council was renewed for an additional two-year period on March 31, 2023. It is determined that the Center for Scientific Review Advisory Council is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Claire Harris, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of VerDate Sep<11>2014 17:12 May 03, 2023 Jkt 259001 28571 Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), Telephone (301) 496– 2123, or harriscl@mail.nih.gov. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: April 28, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. National Heart, Lung, and Blood Institute; Notice of Closed Meeting [FR Doc. 2023–09440 Filed 5–3–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; NHLBI Mentored Transition to Independence Study Section. Date: June 15–16, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, RKL1, 6705 Rockledge Drive, Bethesda, MD 20890 (Virtual Meeting). Contact Person: Giuseppe Pintucci, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 205–H, Bethesda, MD 20892, (301) 827–7969, Pintuccig@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: April 28, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–09438 Filed 5–3–23; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00113 Fmt 4703 Sfmt 4703 National Institutes of Health Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Heart, Lung, and Blood Initial Review Group; Clinical Trials Review Study Section. Date: June 22, 2023. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 1, 6705 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Keary A Cope, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 209–A, Bethesda, MD 20892–7924, (301) 827–7912, copeka@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: April 28, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–09451 Filed 5–3–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting for the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC) Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS). AGENCY: E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 88, Number 86 (Thursday, May 4, 2023)]
[Notices]
[Pages 28570-28571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09521]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIGMS Initial Review Group Training and 
Workforce Development Study Section-D; Review of IMSD and PREP 
Applications.
    Date: June 8-9, 2023.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 
Wisconsin

[[Page 28571]]

Avenue, Bethesda, Maryland 20892 (Hybrid Meeting).
    Contact Person: Marc Rigas, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Institutes of General Medical 
Sciences, National Institute of Health, 45 Center Drive, Room 
3AN18C, Bethesda, Maryland 20892, 301-827-0648, [email protected].

    Name of Committee: NIGMS Initial Review Group Training and 
Workforce Development Study Section-C; Review of G-RISE, IMSD, and 
PREP Applications.
    Date: June 15-16, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Bethesdan Hotel, Tapestry Collection by Hilton, 8120 
Wisconsin Avenue, Bethesda, Maryland 20892 (Hybrid Meeting).
    Contact Person: Sonia Ivette Ortiz-Miranda, Ph.D., Scientific 
Review Officer, Scientific Review Branch, National Institute of 
General Medical Sciences, National Institutes of Health, 45 Center 
Drive, MSC 6200, Bethesda, Maryland 20892, 301-402-9448, 
[email protected].

    Information is also available on the Institute's/Center's home 
page: www.nigms.nih.gov/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program No. 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: May 1, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-09521 Filed 5-3-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.